Celldex Therapeutics, Inc. <CLDX.O>: Morgan Stanley raises target price to $57 from $50
CLDX•Related News
Auddia Announces Appointment Of Former U.S. Secretary Of Defense Mark T. Esper To LT350 Board Of Directors
AUUD•
US fixed 30-year mortgage rate jumps to 7.12%, MBA says
TLT•
Tortoise Energy Infrastructure Enters Distribution Agreement For Up To 2,500,000 Common Shares
TYG•
Walker & Dunlop’s 2026 Apprise Outlook - Appraisers Have Earned A Seat At The Table Well Before CRE Deals Get Done
WD•
Ani Pharmaceuticals Announces The FDA Approval Of Everolimus Tablets For Oral Suspension
ANIP•